Related Experiment Video
Updated: Jul 10, 2026
04:22
Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
Repeated procedures for colorectal liver metastases.
Vladislav Treska1, Tomas Skalicky, Vaclav Liska
1Department of Surgery, University Hospital, Faculty of Medicine Pilsen, Czech Republic. treska@fnplzen.cz
Hepato-Gastroenterology
|November 21, 2007
Summary
Repeated liver procedures offer a significant survival benefit for patients with recurrent colorectal liver metastases (CRLM). These interventions are indicated and prolong life for patients with CRLM recurrence.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Colorectal Cancer Management
Background:
- Colorectal liver metastases (CRLM) recur in 45-80% of patients after primary liver surgery.
- Recurrent CRLM often leads to mortality within 1 year without further surgical options.
- Evaluating long-term outcomes of repeat liver procedures is crucial for patient management.
Purpose of the Study:
- To assess the long-term efficacy of repeated liver procedures for recurrent CRLM.
- To compare survival and disease-free intervals after repeat procedures versus single procedures.
- To determine the indication for repeated liver surgeries in CRLM recurrence.
Main Methods:
- Analysis of 151 patients with CRLM undergoing liver surgery between 2000-2005.
- 24 patients underwent repeated liver procedures (51 total) 6-37 months post-primary surgery.
- Comparison of outcomes with 127 patients who had only one liver procedure.
Main Results:
- Zero 30-day mortality in the repeated procedure group (N=24).
- 1, 2, and 3-year survival rates for repeated procedures: 83.3%, 64.8%, 34.3%.
- 1, 2, and 3-year survival rates for single procedures: 76.6%, 51.9%, 31.9% (p < 0.08).
Conclusions:
- Repeated liver procedures are indicated for recurrent CRLM.
- These interventions significantly prolong survival in patients with CRLM recurrence.
- Repeat surgery offers a viable option for improving long-term outcomes in selected patients.
